InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by CHURCH KEVIN, Vice-Président de la Découverte. Officer active across 1 companies, notably Athira Pharma, Inc.. Aggregated, 10 reports have been recorded. The latest transaction was filed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
010,000 shares0
Common Stock
SEC:0001209191-22-039336:0·
€1,638243 shares@ €6.74138.1% of flow
Common Stock
SEC:0001209191-22-036067:0·
€3,3003,152 shares@ €1.046935.7% of flow
Common Stock
SEC:0001209191-22-011485·
€3,3003,152 shares@ €1.046916.4% of flow
Common Stock
SEC:0001209191-22-011485:0·
€1,06196 shares@ €11.050111.5% of flow
Common Stock
SEC:0001209191-22-004118·
€1,06196 shares@ €11.05015.3% of flow
Common Stock
SEC:0001209191-22-004118:0·
€2,187185 shares@ €11.82123.7% of flow
Common Stock
SEC:0001209191-21-039625·
€2,187185 shares@ €11.82110.9% of flow
Common Stock
SEC:0001209191-21-039625:0·
€2,6933,152 shares@ €0.854429.1% of flow
Common Stock
SEC:0001209191-21-039242·
€2,6933,152 shares@ €0.854413.4% of flow
Common Stock
SEC:0001209191-21-039242:0·
10 of 10 declarations
About CHURCH KEVIN
Kevin Church is the Vice President of Discovery and Executive VP, Research at Athira Pharma, Inc. In this role, he is responsible for leading research efforts to discover new therapies. His extensive experience in pharmaceutical research enables him to guide teams in developing innovative solutions for neurological diseases. His leadership is crucial in advancing research projects and achieving the company's objectives.
